C-reactive protein and serum amyloid A protein in neonatal infections

Scandinavian Journal of Infectious Diseases

Volumn 32, Issue 3, 2000, Pages 229-235

  Pizzini, C ^a   Mussap, M ^a   Plebani, M ^a   Fanos, V ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN; C REACTIVE PROTEIN;

BACTERIAL INFECTION; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; INFLAMMATION; LIVER; NEWBORN; NEWBORN INFECTION; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS; REVIEW; VIRUS INFECTION;

EID: 0033853817     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540050165848     Document Type: Review

References (104)

1. Neonatal sepsis. Progress in diagnosis and management
2. Antibiotics in neonatal infections: A review
3. Defective production of interleukin-6 by monocytes: A possible mechanism underlying several host defense deficiencies of neonates
4. Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens
5. Acute-phase proteins in perinatal human plasma
6. Proteins of the ″acute-phase″ in prematures and newborns
7. Structure and function of the pentraxins
8. Primary structure of human C-reactive protein
9. Interferon (2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells
10. The major acute-phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein
11. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease
12. A detailed analysis of changes in serum C-reactive protein levels in neonates treated for bacterial infection
13. Origine e significato delle proteine ″maggiori″ della fase acuta
14. C-reactive protein: Structural biology and host defense function
15. C-reactive protein: Structural biology, gene expression and host defense function
16. C-reactive protein and serum amyloid A protein in pregnancy and labour
17. C-reactive protein in pregnancy and in the post-partum period
18. Clinical applications of C-reactive protein in pediatrics
19. Response of C-reactive protein in neonatal group B streptococcal infection
20. Sepsis + C-reactive protein
21. C-reactive protein levels in the extremely premature infant: Case studies and literature review
22. Interleukin-6 concentrations in neonates evaluated for sepsis
23. Interleukin-6 concentrations in neonatal sepsis
24. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection
25. Blood serum concentration of C-reactive protein and interleukin-6 in diagnosis of neonatal infections
26. Interleukin-6: A sensitive parameter for the early diagnosis of neonatal bacterial infection
27. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte stimulating factor in the rat
28. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants
29. C-reactive protein (CRP) response patterns in neonatal septicaemia
30. Serial C-reactive protein levels in the diagnosis of neonatal infection
31. Evaluation of C-reactive protein values in neonatal sepsis
32. Human serum amyloid A has cytokine like properties
33. Regulation of serum amyloid A protein expression during the acute-phase response
34. Serum amyloid A (SAA): An acute phase protein and apolipoprotein
35. Localization of four human serum amyloid A (SAA) protein superfamily genes to chromosome 11p: Characterization of a fifth SAA-related gene sequence
36. Molecular and cellular biology of serum amyloid A
37. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein
38. Characterization of human serum amyloid A protein isoforms separated by two-dimensional electrophoresis by liquid chromatography/electrospray ionization tandem mass spectrometry
39. Purification of serum amyloid A and its isoforms from human plasma by hydrophobic interaction chromatography and preparative isoelectric focusing
40. Human serum amyloid A protein
41. Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice
42. SAA, an apoprotein of HDL: Its structure and function
43. Amyloid protein SAA is associated with high density lipoprotein from human serum
44. Influence of serum amyloid A on cholesterol esterification in human plasma
45. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response
46. Association between serum amyloid A proteins and coronary artery disease: Evidence from two distinct arteriosclerotic processes
47. Serum amyloid A changes high density lipoproteins cellular affinity A clue to serum amyloid A's principal function
48. Serum Amyloid A protein (SAA): A marker for liver allograft rejection in humans
49. The primary structure of serum amyloid A protein in the rabbit: Comparison with serum amyloid A proteins in other species
50. Evolution of the serum amyloid A (SAA) protein superfamily
51. Factors affecting the release of proteases from peripheral blood
52. Degradation of protein SAA to an AA-like fragment by enzymes of monocytic origin
53. Degradation of amyloid proteins by different serine proteases
54. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes
55. Effect of purified SAA on immune response in vitro: Mechanisms of suppression
56. SAA suppression of immune response in vitro: Evidence for an effect on T cell-macrophage interaction
57. Acute phase protein, serum amyloid A, inhibits IL-1 and TNF-induced fever and hypothalamic PGE2 in mice
58. Serum amyloid A, an acute phase protein, inhibits platelet activation
59. Inhibition of cell adhesion to glyco-proteins of the extracellular matrix by peptides corresponding to serum amyloid A. Toward understanding the physiological role of an enigmatic protein
60. Serum amyloid A binds specific extracellular matrix glycoproteins and induces adhesion of resting CD4(T cells
61. Serum amyloid A is chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leucocytes
62. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion
63. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway
64. Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils
65. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts
66. Structural prequisites for serum amyloid A fibril formation
67. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo
68. Fibril formation from recombinant human serum amyloid A
69. Impaired Kuppfer cell function precedes development of secondary amyloidosis
70. Serum and synovial fluid levels of serum amyloid A protein and C reactive protein in inflammatory arthritis
71. Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum A comparison with C-reactive protein
72. Quantitative levels of serum amyloid A protein and other proteins in cerebrospinal fluid and serum of patients with meningitis
73. The differential diagnosis of bacterial and aseptic meningitis using cerebrospinal fluid laboratory tests
74. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza
75. Serum Amyloid A protein in acute viral infections
76. Serum amyloid A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis
77. Amyloidosis in a case of ankylosing spondylitis with a review of the literature
78. Acute-phase proteins in osteoarthritis
79. Serum amyloid A protein concentration in rheumatoid arthritis and its role in monitoring disease activity
80. Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: Relationship to amyloidosis
81. Serum amyloid A protein in acute myocardial infarction
82. Serum amyloid type A may be a predictor of restenosis
83. Risk factors for coronary heart disease and acute-phase proteins. A population-based study
84. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function
85. Serum amyloid A protein in amyloidosis, rheumatic and neoplastic diseases
86. Serum amyloid A in carcinoma of the lung
87. Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer
88. Acute phase response in bronchiectasis and bronchus carcinoma
89. Serum amyloid A to monitor cancer dissemination
90. Serum amyloid A (SAA) variations in patients with cancer: Correlation with disease activity, stage, primary site, and prognosis
91. Acute phase proteins or tumor markers: The role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases
92. A rapid laser immunonephelometric assay for serum amyloid A (SAA) and its application to the diagnosis of kidney allograft rejection
93. Serum amyloid A protein is clinically useful indicator of acute renal allograft rejection
94. 2-microglobulin as markers of renal allograft rejection
95. Serum amyloid A protein: A sensitive indicator of renal allograft rejection in humans Transplantation
96. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection
97. Studio della siero-proteina amiloide A nell'eta neonatale
98. A two-dimensional electrophoretic study of serum amyloid A and C-reactive protein in infants and children
99. Serum amyloid A (SAA) protein compared with C-reactive protein for the evaluation of the acute phase response in preterm newborns: Ppreliminary results
100. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, (1-acid glycoprotein and fibrinogen
101. Comparative study of serum amyloid A protein and C-reactive protein in
102. Monitoring both serum amyloid A protein and C-reactive protein as inflammatory markers in infectious
103. Serum amyloid A protein monitoring for early prediction of kidney allograft rejection